CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells - PubMed (original) (raw)
. 1997 May 1;89(9):3385-95.
Affiliations
- PMID: 9129046
Free article
CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells
S Aigner et al. Blood. 1997.
Free article
Abstract
P-selectin (CD62P) is a Ca2+-dependent endogenous lectin that can be expressed by vascular endothelium and platelets. The major ligand for P-selectin on leukocytes is P-selectin glycoprotein ligand-1 (PSGL-1). P-selectin can also bind to carcinoma cells, but the nature of the ligand(s) on these cells is unknown. Here we investigated the P-selectin binding to a breast and a small cell lung carcinoma cell line that are negative for PSGL-1. We report that CD24, a mucin-type glycosylphosphatidylinositol-linked cell surface molecule on human neutrophils, pre B lymphocytes, and many tumors can promote binding to P-selectin. Latex beads coated with purified CD24 from the two carcinoma cell lines but also neutrophils could bind specifically to P-selectin-IgG. The binding was dependent on divalent cations and was abolished by treatment with O-sialoglycoprotein endopeptidase but not endoglycosidase F or sialidase. The beads were stained with a monoclonal antibody (MoAb) to CD57 (HNK-1 carbohydrate epitope) but did not react with MoAbs against the sialylLe(x/a) epitope. The carcinoma cells and CD24-beads derived from these cells could bind to activated platelets or P-selectin transfected Chinese hamster ovary cells (P-CHO) in a P-selectin-dependent manner and this binding was blocked by soluble CD24. Transfection of human adenocarcinoma cells with CD24 enhanced the P-selectin-dependent binding to activated platelets. Treatment of the carcinoma cells or the CD24 transfectant with phosphatidylinositol-specific phospholipase C reduced CD24 expression and P-selectin-IgG binding concomitantly. These results establish a role of CD24 as a novel ligand for P-selectin on tumor cells. The CD24/P-selectin binding pathway could be important in the dissimination of tumor cells by facilitating the interaction with platelets or endothelial cells.
Similar articles
- Heat stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin.
Aigner S, Ruppert M, Hubbe M, Sammar M, Sthoeger Z, Butcher EC, Vestweber D, Altevogt P. Aigner S, et al. Int Immunol. 1995 Oct;7(10):1557-65. doi: 10.1093/intimm/7.10.1557. Int Immunol. 1995. PMID: 8562500 - CD24 mediates rolling of breast carcinoma cells on P-selectin.
Aigner S, Ramos CL, Hafezi-Moghadam A, Lawrence MB, Friederichs J, Altevogt P, Ley K. Aigner S, et al. FASEB J. 1998 Sep;12(12):1241-51. doi: 10.1096/fasebj.12.12.1241. FASEB J. 1998. PMID: 9737727 - Heat-stable antigen (CD24) as ligand for mouse P-selectin.
Sammar M, Aigner S, Hubbe M, Schirrmacher V, Schachner M, Vestweber D, Altevogt P. Sammar M, et al. Int Immunol. 1994 Jul;6(7):1027-36. doi: 10.1093/intimm/6.7.1027. Int Immunol. 1994. PMID: 7524641 - Structure and function of P-selectin glycoprotein ligand-1.
Moore KL. Moore KL. Leuk Lymphoma. 1998 Mar;29(1-2):1-15. doi: 10.3109/10428199809058377. Leuk Lymphoma. 1998. PMID: 9638971 Review. - The roles of P-selectin in cancer cachexia.
Ling T, Liu J, Dong L, Liu J. Ling T, et al. Med Oncol. 2023 Oct 23;40(11):338. doi: 10.1007/s12032-023-02207-2. Med Oncol. 2023. PMID: 37870739 Review.
Cited by
- The role of galectins in mediating the adhesion of circulating cells to vascular endothelium.
Souchak J, Mohammed NBB, Lau LS, Dimitroff CJ. Souchak J, et al. Front Immunol. 2024 May 22;15:1395714. doi: 10.3389/fimmu.2024.1395714. eCollection 2024. Front Immunol. 2024. PMID: 38840921 Free PMC article. Review. - PSGL-1 decorated with sialyl Lewisa/x promotes high affinity binding of myeloma cells to P-selectin but is dispensable for E-selectin engagement.
O'Dwyer M, Kirkham-McCarthy L, Cerreto M, Foà R, Natoni A. O'Dwyer M, et al. Sci Rep. 2024 Jan 19;14(1):1756. doi: 10.1038/s41598-024-52212-2. Sci Rep. 2024. PMID: 38243063 Free PMC article. - Targeting CD24 in Cancer Immunotherapy.
Chen W, Hu Z, Guo Z. Chen W, et al. Biomedicines. 2023 Nov 27;11(12):3159. doi: 10.3390/biomedicines11123159. Biomedicines. 2023. PMID: 38137380 Free PMC article. Review. - Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy.
Yang Y, Wu H, Yang Y, Kang Y, He R, Zhou B, Guo H, Zhang J, Li J, Ge C, Wang T. Yang Y, et al. Mol Ther Oncolytics. 2023 Nov 4;31:100747. doi: 10.1016/j.omto.2023.100747. eCollection 2023 Dec 19. Mol Ther Oncolytics. 2023. PMID: 38046893 Free PMC article. - Role of Truncated _O_-GalNAc Glycans in Cancer Progression and Metastasis in Endocrine Cancers.
Pinto D, Parameswaran R. Pinto D, et al. Cancers (Basel). 2023 Jun 21;15(13):3266. doi: 10.3390/cancers15133266. Cancers (Basel). 2023. PMID: 37444377 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous